Patents by Inventor Armin Reitmair

Armin Reitmair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140342933
    Abstract: Provided herein are methods and compositions for detection and quantification of one or multiple target miRNA(s) in biological fluids and/or tissue samples using alternating laser excitation (ALEX) single molecule fluorescence spectroscopy, and employing such methods and compositions for diagnostic, prognostic, therapeutic, and/or research applications.
    Type: Application
    Filed: October 26, 2012
    Publication date: November 20, 2014
    Applicant: Nesher Technologies, Inc.
    Inventors: Armin Reitmair, Taiho Kim, Steven Partono
  • Patent number: 5907079
    Abstract: Non-human mammals comprising a disrupted MSH2 gene are disclosed. More particularly, animals having a disruption in one or both alleles of the MSH2 gene or a homolog of the MSH2 gene are disclosed. Animals homozygous for the disruption are viable past the embryonic stage of development but show an increased incidence of lymphoma, intestinal adenomas and carcinomas, and squamous cell tumors of the skin. Specifically disclosed are mice whose genome comprises a disrupted MSH2 gene such that the mice exhibits an increase in the incidence of spontaneous lymphoma over the incidence of spontaneous lymphoma in wild type mice.
    Type: Grant
    Filed: January 18, 1996
    Date of Patent: May 25, 1999
    Assignee: Amgen Canada Inc.
    Inventors: Tak W. Mak, Armin Reitmair